Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-008-9987-x
Annals of Surgical Oncology 15:2096-2103 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Ocuin, L. M.
Right arrow Articles by Kooby, D. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ocuin, L. M.
Right arrow Articles by Kooby, D. A.

Original Article

Comparison of Central and Extended Left Pancreatectomy for Lesions of the Pancreatic Neck

Lee M. Ocuin, MD1, Juan M. Sarmiento, MD1, Charles A. Staley, MD1, John R. Galloway, MD1, Colin D. Johnson, MD2, William C. Wood, MD1 and David A. Kooby, MD1

1 Department of Surgery, Emory University School of Medicine, Winship Cancer Institute, 1365C Clifton Rd, NE, 2nd Fl, Atlanta, GA 30322, USA
2 University Surgical Unit, University of Southampton School of Medicine, Southampton, UK

Correspondence: Address correspondence and reprint requests to: David A. Kooby, MD; E-mail: dkooby{at}emory.edu

Background: Central pancreatectomy (CP) is a parenchyma-sparing alternative to extended left pancreatectomy (ELP) for tumors of the pancreatic neck. We compared short- and long-term outcomes for the two approaches.

Methods: Patients who underwent CP or ELP from 2000–2007 for neoplasms of the neck were identified. Charts were reviewed for patient, treatment, and outcome data. Long-term and quality-of-life (QoL) data were gathered through Institutional Review Board (IRB)-approved telephone interviews and questionnaires European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, and QLQ-PAN26.

Results: 31 patients were identified; 13 underwent CP and 18 underwent ELP. Median follow-up was 29 months (range 5–90). Groups did not differ in age, American Society of Anesthesiologists (ASA) class, or preexisting diabetes mellitus (DM). CP patients had less gland resected (5.7 ± 2.1 cm versus 10.8 ± 2.8 cm) and lower postoperative mean blood glucose levels (120 ± 15 mg/dl versus 136 ± 24 mg/dl). CP patients experienced more complications (92% versus 39%), but no significant difference in major complications (38%, CP versus 17%, ELP; P = 0.17) or hospital stay (9 ± 3 days, CP versus 7.5 ± 4 days, ELP). There was one perioperative death in the CP group, unrelated to surgical technique. Questionnaire analysis showed no differences in functional or symptom scales. New-onset exocrine insufficiency was not significantly different between the groups (10%, CP versus 27%, ELP; P = 0.62), but the ELP group had a higher rate of new-onset DM (57% versus 11%; P = 0.04).

Conclusion: CP is associated with more complications than ELP, but no difference in long-term QoL. Due to the lower incidence of postoperative DM, CP can be recommended for healthy patients with indolent tumors of the pancreatic neck.

Key Words: Surgical technique • Pancreas neoplasm • Postoperative complications • Diabetes mellitus • Pancreatic fistula • Exocrine insufficiency







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.